Lilly’s Alimta ready for UK launch
November 2, 2004Lilly's chemotherapy drug Alimta is to be launched in the UK for the treatment of malignant pleural mesothelioma, a type …
Mission to maximise
November 2, 2004We all know that 'less is more'. What clearer mission could you have as a marketer – take this product …
Black box warning for antidepressants in US
November 2, 2004The industry's biggest selling antidepressants will all have to carry the strongest possible warnings in the US, after the FDA …
Industry ready to reply after critics savage practices
November 2, 2004UK regulator the MHRA and the pharmaceutical industry have been condemned for being engaged in a closed and uncritical relationship, …
Lonngren lashes out at late warning
November 1, 2004EMA, EMEA, Lonngren, Vioxx
Thomas Lonngren, the head of Europe’s medicines regulator the EMEA has spoken out about Merck’s withdrawal of Vioxx, saying the …
Nanotechnology: small could be big
October 27, 2004Nanotechnology is starting to fuel the imagination and commercial aspirations of pharma companies, but sound strategies for intellectual property protection …
Pfizer warns of slowdown in 2005
October 27, 2004Pfizer has warned that growth in 2005 could be held back by generic competition and other increasing market pressures.The company's …
Prexige launch delayed
October 27, 2004Novartis has delayed the launch of its potential blockbuster painkiller Prexige until 2007, in the wake of Vioxx's withdrawal. The …
Cipralex shows fewer side-effects than Efexor
October 25, 2004Lundbeck says two new studies prove that patients taking its antidepressant Cipralex (escitalopram) gain relief faster and suffer fewer side-effects …
Equality champion to tackle NHS diversity agenda
October 21, 2004The NHS has engaged its first equality and human rights director to head up its diversity agenda. Surinder Sharma has …
Abbott third quarter profits grow as Humira sales soar
October 21, 2004Abbott Laboratories' third quarter profits grew by 8.7% to $853 million, driven by global sales increases of 10.2%, which were …
Buoyant Roche to enter cholesterol market
October 21, 2004Roche has announced an alliance with a Japanese company to develop and market JTT-705 a promising new treatment for cholesterol.The …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
